Waldenstrom's macroglobulinemia: A retrospective analysis of 40 patients from 1972 to 2001

Seminars in Oncology

Volumn 30, Issue 2, 2003, Pages 236-238

  Ngan, S ^a   Rohatiner, A Z S ^a   Matthews, J ^a   Williams, A ^a   Amess, J A L A ^a   Norton, A ^a   Lister, T A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE; UNITED KINGDOM; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0242684427     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonc.2003.50083     Document Type: Article

References (22)

1. Mackenzie MR, Fudenberg HH: Macroglobulinemia: An analysis of forty patients. Blood 39:874-889, 1972
2. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
3. Dimopoulos MA, Panayiotidis O, Moulopoulos LA, et al: Waldenstrom's macroglobulinema: Clinical features, complications, and management. J Clin Oncol 18:214-226, 2000
4. Crawford J, Cox EB, Cohen HJ: Evaluation of hyperviscoisty in monoclonal gammopathies. Am J Med 79:13-22, 1985
5. Morel L, Basch A, Danon F, et al: Pathology of the kidney in Waldenstrom's macroglobulinemia. N Engl J Med 283:123-127, 1970
6. Schwab PJ, Fahey JL: Treatment of Waldenstrom's macroglobulinemia by plasma pheresis. N Engl J Med 263:574-579, 1960
7. Dimopoulos M, Weber D, Delasalle K, et al: Primary therapy of Waldenstrom's macroglobulinemia. Blood 82:562a, 1993(supp 1, abstr 2234)
8. Zinzani PL, Gherlinzoni F, Bendandi M, et al: Fludarabine treatment in resistant Waldenstrom's macroglobulinemia. Eur J Haematol 54:120-123, 1995
9. Ledlond V, Ben-Othman T, Deconinick E, et al: Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases. Groupe Cooperatif Macroglobulinemie. J Clin Oncol 16:2060-2064, 1998
10. Foran JM, Rohatiner AZ, Coiffier B, et al: Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol 17:546-553, 1999
11. Mclaughlin P, Grillo-Lopez AJ, Link BK, et al: Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825-2830, 1998
12. Dimopoulos MA, Zervas C, Zomas A, et al: Treatment of Waldenstrom's macroglobulinemia with Rituximab. J Clin Oncol 20:2327-2333, 2002
13. Kyle RA, Greipp PR, Gertz MA, et al: Waldenstrom's macroglobulinemia: A prospective study comparing daily with intermittent oral chlorambucil. B J Haematol 108:737-742, 2000
14. Dimopouloa MA, Alexanian R: Waldenstrom's macroglobulinemia. Blood 83:1452-1459, 1994
15. Case DC, Ervin TJ, Boyd MA: Long term results and disease characteristics of patients with Waldenstrom's macroglobulinemia treated with M-2 protocol. Blood 82:561a, 1993 (suppl 1, abstr 2230)
16. Dimopoulos MA, Kantarjian H, Weber D, et al: Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694-2698, 1994
17. Kantarjian HM, Alexanian R, Koller CA, et al: Fludarabine therapy in macroglobulinemic lymphoma. Blood 75:1928-1931, 1990
18. Pott C, Unterhalt M, Sandford D, et al: Fludarabine as a single agent and in combination with mitoxantrone and dexamethasone in relapsed and refractory low-grade non-Hodgkin's lymphoma. Ann Haematol 68:A2, 1994 (suppl 1, abstr)
19. Leblond V, Levy V, Maloisel F, et al: Multicenter, randomized comparative trail of Fludarabine and the combination of cyclophosphamide-doxorubicin-prednisolone in 92 patients with Waldenstrom's macroglobulinemia in first relapse or with primary refractory disease. Blood 98:2640-2644, 2001
20. Facon T, Brouillard M, Duhamel A, et al: Prognostic factors in Waldenstrom's macroglobulinemia: A report of 167 cases. J Clin Oncol 11:1553-1558, 1993
21. Gallagher CJ, Gregory WM, Jones AE, et al: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470-1480, 1986
22. Weber D, Dimopoulos MA, Rankin K, et al: A decade of experience: Primary treatment of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine alone or in combination. Blood 98:635a, 2001 (suppl 1, abstr 2660)